<DOC>
	<DOCNO>NCT02374567</DOCNO>
	<brief_summary>The purpose multicenter-study investigate safety psychopharmacological treatment rate adverse drug reaction gerontopsychiatric inpatient . Elderly people high risk develop side effect pharmacological treatment due alter metabolic situation , high comorbidity rate often polypharmacy . Furthermore gerontopsychiatric patient often articulate symptom clearly , example due pronounce cognitive impairment . The aim study gain valid data possible adverse drug reaction rate , potential risk factor outcome , well medical prescription practises . To assess outcomes intensive pharmacovigilance-monitoring conduct five participate study site . At Baseline demographic data , previous present disorder , use drug , previous present medication , quality life , cognitive function , physical examination result , laboratory result ECG assess . Afterwards patient visit weekly screen possible adverse drug reaction . All adverse drug reaction cod MedDRA-system . In case possible serious adverse drug reaction serum level psychotropic substance applicated assessed . Drug combination analyse use establish advanced bioinformatic tool ( mediQ ) . Diagnosis , medication intake possible adverse drug reaction document continually . 2 week discharge ward , patient contact phone ass catamnestic data .</brief_summary>
	<brief_title>Pharmacovigilance Gerontopsychiatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychophysiologic Disorders</mesh_term>
	<mesh_term>Perphenazine</mesh_term>
	<mesh_term>Flupenthixol</mesh_term>
	<mesh_term>Fluphenazine</mesh_term>
	<mesh_term>Fluphenazine depot</mesh_term>
	<mesh_term>Fluphenazine enanthate</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Chlorprothixene</mesh_term>
	<mesh_term>Benperidol</mesh_term>
	<mesh_term>Bromperidol</mesh_term>
	<mesh_term>Perazine</mesh_term>
	<mesh_term>Clopenthixol</mesh_term>
	<mesh_term>Methotrimeprazine</mesh_term>
	<mesh_term>Fluspirilene</mesh_term>
	<mesh_term>Pipamperone</mesh_term>
	<mesh_term>Pimozide</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<mesh_term>Thioridazine</mesh_term>
	<mesh_term>Sertindole</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Flupenthixol decanoate</mesh_term>
	<mesh_term>Oxazepam</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<mesh_term>Zopiclone</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Chlormethiazole</mesh_term>
	<mesh_term>Clomethiazole edisylate</mesh_term>
	<mesh_term>Nitrazepam</mesh_term>
	<mesh_term>Flurazepam</mesh_term>
	<mesh_term>Bromazepam</mesh_term>
	<mesh_term>Lormetazepam</mesh_term>
	<mesh_term>Brotizolam</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<mesh_term>S 20098</mesh_term>
	<mesh_term>Chloral Hydrate</mesh_term>
	<mesh_term>Triazolam</mesh_term>
	<mesh_term>Zaleplon</mesh_term>
	<mesh_term>Tranylcypromine</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Imipramine</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<mesh_term>Maprotiline</mesh_term>
	<mesh_term>Nicergoline</mesh_term>
	<mesh_term>Opipramol</mesh_term>
	<mesh_term>Trimipramine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Biperiden</mesh_term>
	<mesh_term>Hydroxyzine</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<mesh_term>Doxepin</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Moclobemide</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Clobazam</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Age 65+ year old Inpatients treat one geriatric psychiatry study site . Signed consent form ( Patient and/or legally authorized custodian ) Patients incapable give inform consent legally authorize custodianship . Parallel participation another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>geriatric psychiatry</keyword>
	<keyword>pharmacovigilance</keyword>
</DOC>